Director James F. Comer of Wilson Bank Holding Co filed a Form 4 on November 3, 2026, disclosing the exercise of stock appreciation rights and non-qualified stock options in Wilson Bank Holding Co, each involving 5,000 shares of common stock.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 on November 3, 2026, summarizing the terms of 5-year S&P 500 Futures Excess Return Index Uncapped Accelerated Barrier Notes with a scheduled pricing date of November 24, 2026.
Leidos Holdings, Inc. filed its Form 10-Q for the quarterly period ended October 2, 2026, with the SEC on November 3, 2026, reporting third-quarter revenues of $4.630 billion and net income attributable to common stockholders of $410 million.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) pursuant to Rule 433 on November 3, 2026, disclosing preliminary terms for 5-year S&P 500 Futures Excess Return Index Uncapped Accelerated Barrier Notes with a pricing date of November 30, 2026.
Christopher L. Caldwell, President, CEO, and Director of Community Bancorp /VT (NASDAQ:CMTV), filed a Form 4 on November 3, 2026, disclosing an open-market purchase of 500 shares of Community Bancorp common stock on that same date.
Cynthia Pussinen, CEO and Director of Estrella Immunopharma, Inc., filed an initial statement of beneficial ownership on November 3, 2026, reporting no securities held as of the triggering event date of October 25, 2026.
Shin Dongmin, Managing Director of Advasa Holdings, Inc., filed an initial statement of beneficial ownership (Form 3) on November 3, 2026, disclosing zero shares of common stock held directly.
Hagerty, Inc. filed its quarterly report on Form 10-Q with the SEC on November 3, 2026, covering the three and nine months ended September 30, 2026, for its Class A common stock listed on NYSE:HGTY.
H. Lynn Moore Jr., President and CEO of Tyler Technologies Inc, filed a Form 4 on November 3, 2026, reporting the exercise of 10,000 stock options and the subsequent sale of 10,000 shares of common stock on October 30, 2026.
David Sylvester, retired CFO of HNI Corporation, filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 26,451 shares of HNI common stock on the New York Stock Exchange, with an aggregate market value of $1,129,419.